Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We just broke a penny! Congrats to all the believers. This will be an epic run. Trading like the float is locked.
$TRKG - Going much higher
Every time I put in an order in on Friday it would shoot up 50%-100 percent. Had to chase it but I believe this is the ground floor. TRKG on the breakout boards now.
Heavy loading Monday morning for this weeks run $$$ #1000%gainer
$TRKG
#TRKG
500% today. Next week is going to be fun :)
$TRKG
.0029s going. This will close at at HOD and Next we we run even harder! L2 is so thin.
$TRKG
Just loaded more! Need to load up before the news!
Just tried to buy this with scottrade and they said I couldn't. So pissed as this is a great time to get in. Time to switch platforms. Any recommendations?
Just joined the party. $TRKG moves up quick!
Just slapped the ask. Loaded 300k shares and will be adding more. .25 target zone
This will close at HOD
$eled
#eled
Added more just now. The 52 week high is 485.60!
#200%GainsEasy
#NasdaqHereWeCome
GBSN about to blow! Shorties better cover. Going even higher tomorrow.
# FDAapproved
#GBSN
$GBSN
The last FDA filing got approved in as little as 57 days. We are now on day 108 waiting for the latest filing. I have a feeling we will get news very soon about latest FDA approval. Huge potential here.
#GBSN
$GBSN
10 Reasons to buy GBSN
1)
Received FDA clearance for its Bordetella Direct Test on March 31 (within 57 days of submission)
The Centers for Disease Control and Prevention (CDC) estimates that globally there are approximately 16 million cases of pertussis per year
2)
received clearance from the FDA in April 2015 for our Group B Strep test and launched it commercially in June 2015.
Group B Strep can transmitted to a newborn during childbirth and is the single largest cause of meningitis in newborn infants therefore every pregnant woman in the United States is tested for Group B Strep in the late third trimester
3)
FDA clearance for our STEC test in March 2016. We launched the product commercially in August of 2016.
MRSA, is a potentially life-threatening. Our STEC Test is designed to be a rapid test that identifies Shiga toxin produced by E. coli , including E. coli O157 specifically which is the most serious type of E. coli contracted from contaminated food.
4)
We received FDA clearance for our Staph ID/R panel in March 2016. We launched the product commercially in September of 2016
Staphylococcus aureus is a major cause of hospital and community-acquired infections and is associated with high rates of morbidity and mortality. This test is designed to produce a result in less than one hour. Rapid diagnosis of Staph blood infections has been shown, In a report published in Clinical Practice in 2010, to save up to approximately $7,000 per patient and shorten the length of hospital stays by 6.2 days.
5)
C diff infections are often life-threatening and can create a significant financial burden for hospitals. As a hospital-acquired infection, costs associated with the care of patients with C diff are not covered by insurance or Medicaid/Medicare. C diff infection rates when a hospital switched from culture to molecular testing — reducing cost and improving patient outcomes
6)
Pipeline:
Two assays that have been submitted to the FDA for review.
A test for pertussis and a food borne pathogen panel. Additionally, we have three other assays in various stages of product development: (i) a pre-surgical nasal screen for Staphylococcus aureus, or SA, (ii) a panel for candida blood infections and, (iii) a test for CT/NG.
7)
Our customers consist of hospitals, clinics, laboratories and other healthcare providers in the United States, the European Union.
8)
License Agreements
BioHelix. We hold non-exclusive licenses to key technologies from BioHelix related to isothermal amplification of nucleic acid targets, utilizing helicase-dependent amplification, or HDA.
9)
Market Opportunity
We believe the global market for molecular diagnostic testing is approximately $5.0 billion per year and will experience a growth rate of approximately 12% per year over the course of the next several years based on research published by outside market research firms. We believe our proprietary sample-to-result platform is best suited to address a subset of this market, including hospital-acquired infections and other infectious diseases.
10)
Similar company stock prices:
We primarily compete with other molecular diagnostic testing manufacturers, such as Hologic (Stock Price $42.76), Meridian Bioscience, Inc. (Stock price: $13.15), Qiagen NV (Stock price: $28.20), GenMark Diagnostics (Stock Price: $13.12). We believe that we compete primarily on the basis of our platform’s speed, accuracy, ease of use and relatively low cost. We believe that the approval of additional assays will make our solution more attractive to our customers and prospective customers.
Source:
Annual GBSN 10-k
$GBSN
#GBSN
.01 coming! FDA approval. Here we go!
I'm about to take out those .0043s. $GBSN
Massive run just beginning. #GBSN
#GBSN about to break out! .0036 almost gone.
$GBSN
Next leg up is here. Here we go.
#GAHC
$GAHC
Gap filled and support found. Not much in the way on the ask. Break .0045 and we fly.
This is so thin on L2. Going to a penny by end of week.
.0008 Gap filled and ask has thinned out. Time to move up.
This pullback is healthy. Looking forward to the next run $$$.
Good morning L2. Green today. Lets break .01
This run is just getting started.
$deac
#deac
Im in. This stock is a monster runner.
Monthly chart is smoking hot!
http://i68.tinypic.com/2lj29go.png
I predict we hit .04 by end of week. Higher with news.
Go #SGBY
Slapped the ask twice this morning. Very likely to close above .03 today #SGBY
Glad I joined the party early. This is still under the radar. Soon we will fly. Anyone have a screenshot of Level 2? Any suggestions on what platform to use for Level 2.
Slapped the ask for 325k shares. Next week we go back up quickly with such a low float.
This thing is about to pop!
$newc #newc
I just slapped the ask to add to my position. This is going back up my end of day. GLTA
#SGBY
I just got in. The 4.7 million bid tells me that this stock is gaining major interest. Every gram of cannabis in Oregon has to be tested before its sold. California is about to do the same. We should see a new 52 week high soon.
1st post. Looking forward to the run that just started. Good luck to all.
#TRTC